EUVIMEDEUVIMED entdecken
Crossref

Impact of Colchicine Monotherapy on the Risk of Acute Pericarditis Following Atrial Fibrillation Ablation

Sanghamitra Mohanty, Prasant Mohanty, Danielle Kessler, Carola Gianni, Karim K Baho, Trevor Morris, Tuna Yildiz, Angel Quintero Mayedo, Bryan MacDonald, Domenico G Della Rocca, Amin Al-Ahmad, Mohamed Bassiouny und 5 weitere

JACC: Clinical Electrophysiology · 2023-07 · 9 (7) · 1051-1059

DOI: 10.1016/j.jacep.2023.01.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2023-07. Verfasst von Sanghamitra Mohanty und 16 weiteren Autor:innen. Beteiligte Einrichtung: Texas Cardiac Arrhythmia Institute, St David's Medical Center, Austin, Texas, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pericarditis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute pericarditis is a known complication of ablation procedures for atrial fibrillation (AF). OBJECTIVES: This study aimed to evaluate the benefits of colchicine monotherapy in terms of reducing the risk of pericarditis and related hospitalization rate in AF patients undergoing catheter ablation. METHODS: Consecutive AF patients undergoing first catheter ablation were classified into 3 groups based on their colchicine use: Group 1: no colchicine; group 2: colchicine from 7 days before to 1 month after ablation; and group 3: colchicine from the day of the procedure to 1 month after. Standard institutional protocol was used to follow all patients for 1 year. RESULTS: A total of 1,075 patients were classified into groups 1 (n = 607), 2 (n = 213), and 3 (n = 255). Symptoms of acute pericarditis were reported in 129 patients (12%): group 1: n = 106 (17.5%); group 2: n = 4 (1.9%); and group 3: n = 19 (7.5%); P < 0.001. Rate of mild-moderate as well as severe pericarditis were significantly lower in group 2. In the multivariable regression analysis, pre- and post-ablation colchicine use was seen to be associated with significantly lower risk of acute pericarditis and related hospitalization compared with the other 2 groups. In addition, at 1-year follow-up, arrhythmia-free survival rate was significantly higher in paroxysmal AF patients receiving colchicine compared with the no-colchicine population. CONCLUSIONS: Colchicine therapy starting 7 days before to 1 month after the ablation procedure was associated with significantly lower risk of acute pericarditis and related hospitalization. In addition, paroxysmal AF patients receiving colchicine had a higher arrhythmia-free survival rate compared with those not receiving colchicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationPericarditisHumansTreatment OutcomeColchicine

Stichwörter der Autor:innen

acute pericarditisatrial fibrillationcatheter ablationcolchicineparoxysmal AFpersistent AF

Substanzen

Colchicine

Autor:innen und Institutionen

  • Texas Cardiac Arrhythmia Institute, St David's Medical Center, Austin, Texas, USA.
  • Texas Cardiac Arrhythmia Institute, St David's Medical Center, Austin, Texas, USA; Albert Einstein College of Medicine at Montefiore Hospital, New York, New York, USA.
  • Texas Cardiac Arrhythmia Institute, St David's Medical Center, Austin, Texas, USA; Interventional Electrophysiology, Scripps Clinic, San Diego, California, USA; Metro Health Medical Center, Case Western Reserve Universi…

Zitieren

APA

Mohanty, S., Mohanty, P., Kessler, D., Gianni, C., Baho, K. K., Morris, T., Yildiz, T., Quintero Mayedo, A., MacDonald, B., Della Rocca, D. G., Al-Ahmad, A., Bassiouny, M., Gallinghouse, G. J., Horton, R., Burkhardt, J. D., di Biase, L., & Natale, A. (2023). Impact of Colchicine Monotherapy on the Risk of Acute Pericarditis Following Atrial Fibrillation Ablation. JACC: Clinical Electrophysiology, 9(7), 1051-1059. https://doi.org/10.1016/j.jacep.2023.01.037

Vancouver

Mohanty S, Mohanty P, Kessler D, Gianni C, Baho KK, Morris T, et al. Impact of Colchicine Monotherapy on the Risk of Acute Pericarditis Following Atrial Fibrillation Ablation. JACC: Clinical Electrophysiology. 2023;9(7):1051-1059. doi:10.1016/j.jacep.2023.01.037

BibTeX
@article{Mohanty2023,
  author = {Mohanty, Sanghamitra and Mohanty, Prasant and Kessler, Danielle and Gianni, Carola and Baho, Karim K and Morris, Trevor and Yildiz, Tuna and Quintero Mayedo, Angel and MacDonald, Bryan and Della Rocca, Domenico G and Al-Ahmad, Amin and Bassiouny, Mohamed and Gallinghouse, G Joseph and Horton, Rodney and Burkhardt, John D and di Biase, Luigi and Natale, Andrea},
  title = {Impact of Colchicine Monotherapy on the Risk of Acute Pericarditis Following Atrial Fibrillation Ablation},
  journal = {JACC: Clinical Electrophysiology},
  year = {2023},
  volume = {9},
  number = {7},
  pages = {1051--1059},
  doi = {10.1016/j.jacep.2023.01.037}
}
Kostenlos starten →